NCT00729222View on ClinicalTrials.gov

Hemodynamic Effects of Rolofylline in the Treatment of Patients With Heart Failure (7418-503)

PHASE2CompletedINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

November 30, 2008

Primary Completion Date

March 31, 2009

Study Completion Date

March 31, 2009

Conditions
Heart Failure
Interventions
DRUG

Comparator: Placebo

rolofylline placebo IV infusion over 4 hours.

DRUG

rolofylline

rolofylline 30 mg IV infusion over 4 hours.

Sponsors

Collaborators (1)

NovaCardia, Inc.
All Listed Sponsors
collaborator

NovaCardia, Inc.

UNKNOWN

lead

Merck Sharp & Dohme LLC

INDUSTRY